Techno Medica Cash Flow Statement

Financials in millions JPY. Fiscal year is April - March.

Millions JPY. Fiscal year is Apr - Mar.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Net Income	1,319	1,860	1,665	1,851	1,649
Depreciation & Amortization	99	112	108	120	120
Loss (Gain) From Sale of Assets	-	9	2	-	-
Other Operating Activities	-572	-493	-642	-628	-261
Change in Accounts Receivable	392	-723	77	-46	-283
Change in Inventory	-452	-289	-636	416	-286
Change in Accounts Payable	160	-84	217	147	53
Change in Other Net Operating Assets	31	750	96	202	-167
Operating Cash Flow	977	1,142	887	2,062	825
Operating Cash Flow Growth	-14.45%	28.75%	-56.98%	149.94%	-34.99%
Capital Expenditures	-25	-37	-133	-66	-30
Sale (Purchase) of Intangibles	-6	-64	-5	-14	-3
Investment in Securities	-	-	-	2,568	-120
Other Investing Activities	-1	1	-17	1	-
Investing Cash Flow	-32	-100	-155	2,489	-153
Repurchase of Common Stock	-	-3,697	-	-164	-
Common Dividends Paid	-470	-508	-505	-434	-415
Financing Cash Flow	-470	-4,205	-505	-598	-415
Miscellaneous Cash Flow Adjustments	-	-	-1	-	-1
Net Cash Flow	475	-3,163	226	3,953	256
Free Cash Flow	952	1,105	754	1,996	795
Free Cash Flow Growth	-13.85%	46.55%	-62.22%	151.07%	-6.03%
Free Cash Flow Margin	9.61%	10.75%	8.05%	20.58%	8.79%
Free Cash Flow Per Share	137.48	141.76	89.34	234.98	93.60
Cash Income Tax Paid	574	495	644	630	260
Levered Free Cash Flow	674.5	772	572.63	1,817	667
Unlevered Free Cash Flow	674.5	772	572.63	1,817	667
Change in Working Capital	131	-346	-246	719	-683

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.